Literature DB >> 22139708

MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.

Bing Feng1, Rui Wang, Hai-Zhu Song, Long-Bang Chen.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) have been identified as important posttranscriptional regulators involved in various biological and pathological processes of cells, but their association with tumor chemoresistance has not been fully understood.
METHODS: We detected miRNA-200b (miR-200b) expression in different lung adenocarcinoma cell lines and then focused on its roles in regulation of docetaxel chemoresistance. We also identified E2F3 as a novel target of miR-200b.
RESULTS: Based on miRNA microarray data, miR-200b was identified as the most down-regulated miRNA in docetaxel-resistant SPC-A1/DTX cells compared with parental SPC-A1 cells. Ectopic miR-200b expression reversed docetaxel chemoresistance of lung adenocarcinoma cells through cell proliferation inhibition, apoptosis enhancement, and G(2) /M cell cycle arrest. In a nude mouse xenograft model, up-regulation of miR-200b significantly enhanced response of SPC-A1/DTX cells to docetaxel. Luciferase reporters containing the 3' untranslated region sequence of E2F3 messenger RNA were used to demonstrate that miR-200b could directly target E2F3. Small interfering RNA-mediated E2F3 knockdown revealed similar effects as that of ectopic miR-200b expression. Decreased miR-200b expression was also detected in tumor tissues sampled from lung adenocarcinoma patients treated with docetaxel-based chemotherapy and was proved to be correlated with high expression of E2F3, decreased sensitivity to docetaxel, and poor prognosis.
CONCLUSIONS: Our results suggest that down-regulation of miR-200b could lead to E2F3 overexpression and in turn contribute to chemoresistance of lung adenocarcinoma cells to docetaxel.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139708     DOI: 10.1002/cncr.26560

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  59 in total

1.  miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.

Authors:  Kelsey Bolin; Nicholas Rachmaninoff; Kea Moncada; Katharine Pula; Jennifer Kennell; Laura Buttitta
Journal:  Dev Biol       Date:  2016-02-21       Impact factor: 3.582

2.  miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.

Authors:  Youngmi Kim; Deokbum Park; Hyuna Kim; Munseon Choi; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

3.  Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.

Authors:  Yue Zhao; Lu Zhao; Ivan Ischenko; Qi Bao; Bettina Schwarz; Hanno Nieß; Yan Wang; Andrea Renner; Josef Mysliwietz; Karl-Walter Jauch; Peter J Nelson; Joachim W Ellwart; Christiane J Bruns; Peter Camaj
Journal:  Target Oncol       Date:  2015-02-03       Impact factor: 4.493

4.  Tumour angiogenesis regulation by the miR-200 family.

Authors:  Rajesha Rupaimoole; Da Yang; Rehan Akbani; Chad V Pecot; Cristina Ivan; Chunhua Lu; Sherry Wu; Hee-Dong Han; Maitri Y Shah; Cristian Rodriguez-Aguayo; Justin Bottsford-Miller; Yuexin Liu; Sang Bae Kim; Anna Unruh; Vianey Gonzalez-Villasana; Li Huang; Behrouz Zand; Myrthala Moreno-Smith; Lingegowda S Mangala; Morgan Taylor; Heather J Dalton; Vasudha Sehgal; Yunfei Wen; Yu Kang; Keith A Baggerly; Ju-Seog Lee; Prahlad T Ram; Murali K Ravoori; Vikas Kundra; Xinna Zhang; Rouba Ali-Fehmi; Ana-Maria Gonzalez-Angulo; Pierre P Massion; George A Calin; Gabriel Lopez-Berestein; Wei Zhang; Anil K Sood
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 5.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

Review 6.  microRNAs and cancer metabolism reprogramming: the paradigm of metformin.

Authors:  Claudio Pulito; Sara Donzelli; Paola Muti; Luisa Puzzo; Sabrina Strano; Giovanni Blandino
Journal:  Ann Transl Med       Date:  2014-06

7.  miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.

Authors:  Jing Su; Qing Wang; Yiping Liu; Meizuo Zhong
Journal:  Mol Cell Biochem       Date:  2014-03-27       Impact factor: 3.396

Review 8.  MicroRNAs in lung cancer.

Authors:  Pooja Joshi; Justin Middleton; Young-Jun Jeon; Michela Garofalo
Journal:  World J Methodol       Date:  2014-06-26

9.  miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.

Authors:  Jipeng Li; Shanfeng Li; Zhe Chen; Jianhua Wang; Ying Chen; Zhengyang Xu; Mingwei Jin; Wanjun Yu
Journal:  Tumour Biol       Date:  2016-07-26

Review 10.  Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer.

Authors:  Yu Yan; Li-Feng Wang; Rui-Fen Wang
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.